Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]

  • In development
  • GID-TA11498
  • Expected publication date: 

NIHRIO BN: 28716-Vorasidenib-for-Glioma-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)